A. Winge-Main

474 total citations
7 papers, 72 citations indexed

About

A. Winge-Main is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, A. Winge-Main has authored 7 papers receiving a total of 72 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Immunology. Recurrent topics in A. Winge-Main's work include CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cutaneous Melanoma Detection and Management (2 papers). A. Winge-Main is often cited by papers focused on CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cutaneous Melanoma Detection and Management (2 papers). A. Winge-Main collaborates with scholars based in Norway, United Kingdom and Germany. A. Winge-Main's co-authors include Sophie D. Fosså, Jan Gunnar Fjeld, Wolfgang Lilleby, Else Marit Inderberg, Sébastien Wälchli, Gustav Gaudernack, Pierre Dillard, Hakan Köksal, Viví Ann Flørenes and Sylvie Pollmann and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Oncology and Molecular Therapy.

In The Last Decade

A. Winge-Main

6 papers receiving 72 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Winge-Main Norway	4	35	31	30	19	16	7	72
Hui Yi Chew Australia	5	36 1.0×	38 1.2×	33 1.1×	5 0.3×	17 1.1×	8	94
Mengxue Pan China	5	35 1.0×	14 0.5×	42 1.4×	12 0.6×	10 0.6×	6	96
Yuanchuang Li China	6	42 1.2×	16 0.5×	40 1.3×	14 0.7×	8 0.5×	7	101
Haihua Fu China	4	38 1.1×	32 1.0×	35 1.2×	6 0.3×	7 0.4×	7	79
Ylva Paulsson-Karlsson Sweden	7	16 0.5×	18 0.6×	49 1.6×	5 0.3×	11 0.7×	8	85
Adrien Procureur France	4	44 1.3×	16 0.5×	17 0.6×	6 0.3×	21 1.3×	6	68
Dennis Mauricio United States	3	36 1.0×	12 0.4×	23 0.8×	15 0.8×	23 1.4×	6	92
Amy Marshall United States	5	53 1.5×	22 0.7×	22 0.7×	7 0.4×	19 1.2×	7	65
Barchuk As Russia	5	43 1.2×	54 1.7×	23 0.8×	3 0.2×	12 0.8×	24	90
Andrea Mayer-Mokler Germany	5	58 1.7×	20 0.6×	23 0.8×	3 0.2×	48 3.0×	10	77

Countries citing papers authored by A. Winge-Main

Since Specialization

Citations

This map shows the geographic impact of A. Winge-Main's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Winge-Main with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Winge-Main more than expected).

Fields of papers citing papers by A. Winge-Main

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Winge-Main. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Winge-Main. The network helps show where A. Winge-Main may publish in the future.

Co-authorship network of co-authors of A. Winge-Main

This figure shows the co-authorship network connecting the top 25 collaborators of A. Winge-Main. A scholar is included among the top collaborators of A. Winge-Main based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Winge-Main. A. Winge-Main is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Winge-Main, A., et al.. (2024). Use of Immune Checkpoint Inhibitor (ICI) Therapy for Cutaneous Melanoma from 2014 to 2021 in Norway: Insights from Real-World Data. SHILAP Revista de lepidopterología. 2. 100170–100170.

2.

Winge-Main, A., et al.. (2023). Long-term outcomes of stage IIB–IV melanoma patients: nationwide data from Norway. Future Oncology. 19(3). 205–215. 4 indexed citations

3.

Heck, Ansgar & A. Winge-Main. (2021). Silent, isolated ACTH deficiency in malignant melanoma patients treated with immune checkpoint inhibitors. BMJ Case Reports. 14(5). e241981–e241981. 2 indexed citations

4.

Winge-Main, A., Sébastien Wälchli, & Else Marit Inderberg. (2020). T cell receptor therapy against melanoma—Immunotherapy for the future?. Scandinavian Journal of Immunology. 92(4). e12927–e12927. 9 indexed citations

5.

Dillard, Pierre, Hakan Köksal, Sólrún Melkorka Maggadóttir, et al.. (2020). Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy. Molecular Therapy. 29(3). 1199–1213. 21 indexed citations

6.

Winge-Main, A., Trude Eid Robsahm, Marta Nyakas, et al.. (2020). 1150P Long-term outcomes of stage IIB-IV melanoma patients: Nationwide data from Norway. Annals of Oncology. 31. S766–S767. 1 indexed citations

7.

Winge-Main, A., et al.. (2010). Combined Positron Emission Tomography/Computed Tomography in Sunitinib Therapy Assessment of Patients with Metastatic Renal Cell Carcinoma. Clinical Oncology. 23(5). 339–343. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact